Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Equity Income (2016 - 2021)

Milestone Scientific's Equity Income history spans 11 years, with the latest figure at $407050.0 for Q4 2021.

  • For Q4 2021, Equity Income rose 315.84% year-over-year to $407050.0; the TTM value through Sep 2022 reached $407050.0, up 711.42%, while the annual FY2021 figure was $242589.0, 147.83% up from the prior year.
  • Equity Income for Q4 2021 was $407050.0 at Milestone Scientific, up from -$69905.0 in the prior quarter.
  • Across five years, Equity Income topped out at $407050.0 in Q4 2021 and bottomed at -$95857.0 in Q2 2021.
  • The 5-year median for Equity Income is $32225.0 (2019), against an average of $37327.1.
  • The largest annual shift saw Equity Income crashed 126.0% in 2019 before it surged 315.84% in 2021.
  • A 5-year view of Equity Income shows it stood at -$91569.0 in 2017, then surged by 256.43% to $143242.0 in 2018, then crashed by 77.5% to $32225.0 in 2019, then skyrocketed by 203.76% to $97887.0 in 2020, then soared by 315.84% to $407050.0 in 2021.
  • Per Business Quant, the three most recent readings for MLSS's Equity Income are $407050.0 (Q4 2021), -$69905.0 (Q3 2021), and -$95857.0 (Q2 2021).